98 results
Page 2 of 5
8-K
EX-99.1
obvl5w1ht3mndunicob
28 Mar 24
ENDRA Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
4:10pm
8-K
EX-99.1
k2ypfe7082a3gnr
14 Nov 23
ENDRA Life Sciences Reports Third Quarter 2023 Financial Results and Provides Business Update
4:02pm
8-K
EX-99.1
zx5s mvaajt8yj7l
14 Aug 23
ENDRA Life Sciences Reports Second Quarter 2023 Financial Results and Provides a Business Update
4:13pm
8-K
EX-99.2
ajx568ezh3igo
14 Aug 23
ENDRA Life Sciences Reports Second Quarter 2023 Financial Results and Provides a Business Update
4:13pm
8-K
EX-99.1
ngm2jn2r9vg
6 Jul 23
ENDRA Life Sciences Announces Adjournment of
5:25pm
DEFA14A
EX-99.1
ve8w0ukzroqge 4f9
6 Jul 23
Additional proxy soliciting materials
5:25pm
8-K
EX-99.1
hkk4pzp ld
15 May 23
ENDRA Life Sciences Reports First Quarter 2023 Financial Results and Provides a Business Update
12:00am
8-K
EX-99.2
iqcojgk
2 May 23
ENDRA Life Sciences Announces Pricing of Upsized $4.5 Million Public Offering
4:16pm
8-K
EX-99.1
usor 381hh7
2 May 23
ENDRA Life Sciences Announces Pricing of Upsized $4.5 Million Public Offering
4:16pm
424B5
fgakvljxt7xyflchjx
28 Apr 23
Prospectus supplement for primary offering
4:51pm
8-K
EX-99.1
v8o85kfye3dj735ryz49
14 Nov 22
ENDRA Life Sciences Reports Third Quarter 2022 Financial Results and Provides Business Update
4:32pm
8-K
EX-99.1
4v6c04vanioxa4ln
15 Aug 22
ENDRA Life Sciences Reports Second Quarter 2022 Financial Results and Provides Business Update
5:17pm
8-K
EX-99.1
dlyg3ydpe4c7
12 May 22
ENDRA Life Sciences Reports First Quarter 2022 Financial Results and Provides Business Update
4:06pm